Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,632 | 377 | 87.0% |
| Travel and Lodging | $858.76 | 3 | 9.8% |
| Education | $277.29 | 4 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,326 | 83 | $0 (2024) |
| Teleflex LLC | $1,193 | 9 | $0 (2024) |
| Coloplast Corp | $1,052 | 30 | $0 (2022) |
| ABBVIE INC. | $571.99 | 32 | $0 (2024) |
| PFIZER INC. | $537.29 | 40 | $0 (2024) |
| NeoTract Inc. | $447.84 | 7 | $0 (2020) |
| Endo Pharmaceuticals Inc. | $415.18 | 24 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $385.07 | 21 | $0 (2024) |
| Allergan, Inc. | $251.18 | 16 | $0 (2022) |
| PROCEPT BioRobotics Corporation | $245.75 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,001 | 47 | Teleflex LLC ($199.89) |
| 2023 | $1,950 | 54 | Teleflex LLC ($802.09) |
| 2022 | $1,061 | 58 | ABBVIE INC. ($191.87) |
| 2021 | $951.24 | 51 | Astellas Pharma US Inc ($228.38) |
| 2020 | $927.60 | 35 | NeoTract Inc. ($356.55) |
| 2019 | $751.02 | 45 | Coloplast Corp ($170.82) |
| 2018 | $1,204 | 50 | Astellas Pharma US Inc ($323.25) |
| 2017 | $923.76 | 44 | Coloplast Corp ($391.86) |
All Payment Transactions
384 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: UROLOGY | ||||||
| 11/08/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oncology | ||||||
| 10/28/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Oncology | ||||||
| 10/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Oncology | ||||||
| 09/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: HORMONE THERAPY | ||||||
| 08/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 08/22/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: UROLOGY | ||||||
| 08/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Oncology | ||||||
| 07/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $122.61 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 07/15/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 56 | 7,494 | 13,242 | $2.4M | $489,997 |
| 2022 | 55 | 6,984 | 9,499 | $2.2M | $396,434 |
| 2021 | 46 | 6,410 | 8,831 | $2.1M | $394,349 |
| 2020 | 42 | 5,816 | 7,751 | $1.7M | $284,802 |
All Medicare Procedures & Services
201 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,140 | 1,572 | $393,000 | $131,263 | 33.4% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Office | 2023 | 18 | 89 | $178,000 | $55,749 | 31.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 224 | 1,005 | $180,900 | $46,726 | 25.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 175 | 190 | $110,200 | $29,402 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 362 | 433 | $71,445 | $23,912 | 33.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 21 | 168 | $570,000 | $22,654 | 4.0% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Office | 2023 | 18 | 18 | $54,000 | $16,435 | 30.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 588 | 772 | $46,320 | $13,865 | 29.9% |
| 87084 | Screening test for pathogenic organisms with colony count | Office | 2023 | 296 | 442 | $19,890 | $11,726 | 59.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 2,100 | $31,500 | $10,452 | 33.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 156 | 285 | $42,810 | $9,972 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $36,270 | $9,623 | 26.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 49 | 50 | $30,000 | $8,436 | 28.1% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 184 | 207 | $46,575 | $8,111 | 17.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 675 | 914 | $18,280 | $7,646 | 41.8% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 48 | 49 | $40,327 | $6,503 | 16.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 69 | 69 | $22,425 | $5,165 | 23.0% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 35 | 110 | $19,800 | $4,942 | 25.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 11 | 11 | $35,750 | $4,874 | 13.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 48 | 49 | $12,250 | $4,810 | 39.3% |
| 55899 | Other procedure on male genital system | Office | 2023 | 68 | 68 | $56,400 | $3,769 | 6.7% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 11 | 14 | $12,124 | $3,725 | 30.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 35 | $11,900 | $3,572 | 30.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 79 | 87 | $9,135 | $3,082 | 33.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 346 | 439 | $22,828 | $3,069 | 13.4% |
About Dr. Jeffrey Thibodeaux, MD
Dr. Jeffrey Thibodeaux, MD is a Urology healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275634107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Thibodeaux, MD has received a total of $8,768 in payments from pharmaceutical and medical device companies, with $1,001 received in 2024. These payments were reported across 384 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($7,632).
As a Medicare-enrolled provider, Thibodeaux has provided services to 26,704 Medicare beneficiaries, totaling 39,323 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 201 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Lafayette, LA
- Active Since 09/25/2006
- Last Updated 04/25/2014
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1275634107
Products in Payments
- XTANDI (Drug) $1,039
- UROLIFT (Device) $1,002
- UroLift (Device) $447.84
- BOTOX (Biological) $439.64
- XIAFLEX (Biological) $392.47
- GEMTESA (Drug) $356.27
- ENDOUROLOGY (Device) $308.28
- LUPRON DEPOT (Drug) $275.59
- PROVENGE (Drug) $228.54
- AQUABEAM ROBOTIC SYSTEM (Device) $226.13
- MYRBETRIQ (Drug) $218.12
- TITAN (Device) $180.14
- ORGOVYX (Drug) $169.91
- Myrbetriq (Drug) $164.84
- UroLift System (Device) $158.78
- CAMCEVI (Drug) $155.08
- Xtandi (Drug) $136.35
- KEYTRUDA (Biological) $132.26
- Axumin (Drug) $130.79
- Titan (Device) $122.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lafayette
Alexandra Rogers, Md, MD
Urology — Payments: $422,714
Julio Chong, Md, MD
Urology — Payments: $33,092
Timothy Redden, Md, MD
Urology — Payments: $22,908
Dr. William Roth, Md, MD
Urology — Payments: $19,960
Charles Modlin, Md, MD
Urology — Payments: $12,478
Dr. Stanton Regan, M.d, M.D
Urology — Payments: $11,568